MYDCOMBI FDA approval date

The FDA approved MYDCOMBI on 5 May 2023.

FDA approval date
5 May 2023

Drug identity has not yet been verified against registry records

Also recorded as PHENYLEPHRINE HYDROCHLORIDE; TROPICAMIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-05-05DayMYDCOMBIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA215352", "applicant_as_listed_by_fda": "EYENOVIA", "brand_names": ["MYDCOMBI"], "active_ingredients": ["PHENYLEPHRINE HYDROCHLORIDE", "TROPICAMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230505", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026